Business

MariMed to Open Thrive Dispensary in Columbus as Second Ohio Store

mm
Add MyCannabis.com to your preferred sources on Google

MariMed Inc. on September 17, 2026, announced the September 18, 2026, opening of Thrive Dispensary Columbus, the company’s 14th Thrive Dispensary location in five states and its second in Ohio. The Norwood, Massachusetts-based multi-state cannabis operator also operates Thrive Dispensary Tiffin in the western part of the state.

The Columbus dispensary is located on the city’s east side at 2025 Brice Road, where the company transformed a former bank property into a modern retail destination featuring a drive-through window and dedicated curbside parking spots. MariMed characterized the opening as part of its strategic plan to expand its product and retail brands in high-growth markets. The company trades on the CSE and OTCQB under the symbol MRMD.

In the announcement, MariMed described Ohio as among the fastest-growing legal cannabis markets in the country, citing July 2026 sales of $111 million, up 22 percent year over year.

Ohio Cannabis Market by the Numbers

The Ohio Department of Commerce’s Division of Cannabis Control listed 228 dual-use dispensary certificates of operation and 50 provisional dispensary licenses in its By the Numbers program update, last updated September 17, 2026. The document also listed 39 cultivator certificates of operation, comprising 25 Level I dual-use and 14 Level II dual-use certificates, along with 46 dual-use processor certificates of operation and seven dual-use testing laboratories.

Ohio had 473,844 registered medical patients and 42,803 registered caregivers as of July 31, 2026, according to the update, and 490 physicians held certificates to recommend as of September 9, 2026.

Cumulative Ohio cannabis sales through September 5, 2026, totaled $4,289,495,488, with $1,868,032,447 in non-medical sales and $2,421,461,131 in medical sales across 49,553,470 total receipts, the division reported. For the week of July 26 through September 5, 2026, average prices stood at $6.50 per gram of plant material, $18.38 per one-tenth ounce and $23.95 for manufactured products.

MariMed’s Ohio Operations Since 2023

MariMed opened the Thrive Wellness Dispensary medical dispensary in Tiffin on June 12, 2023, its first operational dispensary in Ohio and the 11th it owned or managed across five states at the time, according to the company’s opening announcement. The store, at 318 W. Market Street, was the first dispensary in Seneca County, a western Ohio county of 54,000 residents. MariMed had been awarded a provisional dispensary license in 2022.

The company commenced adult-use retail sales at the Tiffin dispensary on September 24, 2024, after it had operated as a medical-only facility since June 2023, MariMed announced at the time. “We have long believed that Ohio will be one of the country’s largest cannabis markets, and it remains our top priority with respect to mergers and acquisitions to become a vertical operator as quickly as possible,” Chief Executive Officer Jon Levine said in that announcement.

The 2024 release, citing the Ohio Department of Commerce, said Ohio’s medical marijuana industry generated nearly $500 million in 2023 retail sales, a figure expected to grow significantly with the addition of adult-use sales. The release also noted that Ohio’s population of 11.8 million makes it the seventh most populous state in the United States.

MariMed reported second-quarter 2026 revenue of $41.9 million, compared with $39.5 million a year earlier, a GAAP net loss of $3.6 million, compared with a loss of $1.4 million, and non-GAAP Adjusted EBITDA of $3.9 million, compared with $4.8 million, according to its August 12, 2026, earnings release. Levine said revenue increased in both the company’s wholesale and retail businesses, sequentially and year over year, producing the highest quarterly revenue in MariMed’s history.

Retail revenue increased 7 percent sequentially in the second quarter, with revenue rising at 12 of the 13 Thrive Dispensary locations, transactions across the retail network up 7 percent sequentially and Thrive Perks Loyalty Program membership up 14 percent since the beginning of the year, the company reported. Wholesale revenue increased 6 percent sequentially, and distribution of MariMed’s branded products reached 85 percent of available storefronts on a trailing 12-month basis.

MariMed said its Betty’s Eddies fruit chews remained the top-selling edible brand across Massachusetts, Maryland, Illinois and Delaware, and its Vibations drink mix remained a top 10 brand in the same states, citing industry data sources. The company’s brand portfolio also includes Bubby’s Baked, InHouse and Nature’s Heritage. Levine described an “Expand the Brand” growth strategy centered on building a cannabis consumer packaged goods company with top-selling national brands, including entry into new markets through capital-light strategies such as brand licensing.

The official Thrive Dispensaries website lists existing stores in Illinois, in Anna, Casey, Harrisburg, Metropolis and Mt. Vernon; in Maryland, in Annapolis and Upper Marlboro; in Massachusetts, in Beverly, Middleborough and Quincy; in Delaware, in Lewes and Wilmington; and in Tiffin, Ohio, which operates as a medical and non-medical dispensary.

Ava Morales is an AI-generated analyst at MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.